Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan

被引:59
|
作者
Sakurai, K [1 ]
Katoh, M [1 ]
Someno, K [1 ]
Fujimoto, Y [1 ]
机构
[1] Hokkaido Coll Pharm, Dept Biochem, Otaru, Hokkaido 0470264, Japan
关键词
alloxan; apoptosis; mitochondria; reactive oxygen species; INS-1; cell; diabetes;
D O I
10.1248/bpb.24.876
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To evaluate the participation of mitochondrial damage, oxygen radicals and cell death in diabetes mellitus, we designed a way to investigate INS-1 cells, rat pancreatic beta -cell line, to die by treatment with alloxan which generate reactive oxygen species (ROS). Incubation of INS-1 cells with alloxan for 24 h resulted in a decrease in viability of cells as well as inhibition of glucose-stimulated insulin release, this could be prevented by antioxidants, vitamin E and butylated hydroxyanisol (BHA). The formation of a DNA ladder and the distribution of phosphatidylserine at the external surface of plasma membrane were observed as indicators of apoptosis in the cells treated with alloxan at concentrations below 0.5 mM. The formation of DNA ladder was prevented by vitamin E, BHA and catalase. suggesting that the ROS is involved in the process of apoptosis in INS-1 cells treated with alloxan. Lower levels of intracellular ATP, collapse of mitochondrial membrane potential and release of cytochrome c from mitochondria were also observed in INS-1 cells treated with alloxan. suggesting that alloxan caused the damage of mitochondria in cells and was related to the process of apoptosis. In contrast, rat liver RLC-18 cells treated with alloxan were not observed in the decrease of viability. It follows from the present study that mitochondrial damages by ROS generated from alloxan is linked to apoptosis in INS-1 cells.
引用
收藏
页码:876 / 882
页数:7
相关论文
共 50 条
  • [31] The role of calcineurin during dexamethasone-induced apoptosis in insulin secreting ins-1 cells
    Ullrich, Susanne
    Ranta, Felicia
    Avram, Diana
    Duefer, Martina
    Drews, Gisela
    Lang, Florian
    Haering, Hans-Ulrich
    DIABETES, 2007, 56 : A409 - A409
  • [32] Scopoletin protects INS-1 pancreatic β cells from glucotoxicity by reducing oxidative stress and apoptosis
    Park, Jae Eun
    Han, Ji Sook
    TOXICOLOGY IN VITRO, 2023, 93
  • [33] Neutral ceramidase activity inhibition is involved in palmitate-induced apoptosis in INS-1 cells
    Luo, Fen
    Feng, Yamin
    Ma, Huimin
    Liu, Chao
    Chen, Guofang
    Wei, Xiao
    Mao, Xiaodong
    Li, Xingjia
    Xu, Yijiao
    Tang, Shan
    Wen, Honghua
    Jin, Junfei
    Zhu, Qun
    ENDOCRINE JOURNAL, 2017, 64 (08) : 767 - 776
  • [34] Melatonin protects INS-1 pancreatic β-cells from apoptosis and senescence induced by glucotoxicity and glucolipotoxicity
    Lee, Yu Hee
    Jung, Hye Sook
    Kwon, Min Jeong
    Jang, Jung Eun
    Kim, Tae Nyun
    Lee, Soon Hee
    Kim, Mi-Kyung
    Park, Jeong Hyun
    ISLETS, 2020, 12 (04) : 87 - 98
  • [35] The Effects of Camellia sinensis Extract on Proliferation, Apoptosis and Oxidative Stress in Insulinoma INS-1 Cells
    Kacar, Ayse Karatug
    Ersoz, Melike
    Sezekler, Isil
    Coskun, Zeynep Mine
    BEZMIALEM SCIENCE, 2019, 7 (02): : 80 - 85
  • [36] Chebulic Acid Prevents Methylglyoxal-Induced Mitochondrial Dysfunction in INS-1 Pancreatic β-Cells
    Yoo, Hyun-jung
    Hong, Chung-Oui
    Ha, Sang Keun
    Lee, Kwang-Won
    ANTIOXIDANTS, 2020, 9 (09) : 1 - 16
  • [37] EFFECTS OF CYTOKINES ON RAT INSULINOMA INS-1 CELLS
    JANJIC, D
    ASFARI, M
    JOURNAL OF ENDOCRINOLOGY, 1992, 132 (01) : 67 - 76
  • [38] Responses of INS-1 cells to glucose stimulation patterns
    Yang, Fan
    Wang, Jiajia
    Qu, Kaige
    Wei, Huimiao
    Song, Zhengxun
    Xu, Hongmei
    Wang, Zuobin
    Chen, Yujuan
    BIOMATERIALS ADVANCES, 2023, 144
  • [39] Dual effects of diadenosine polyphosphates on INS-1 cells
    Verspohl, EJ
    Johannwille, B
    DIABETOLOGIA, 1998, 41 : A133 - A133
  • [40] Regulation of insulin secretion by GABA in INS-1 cells
    Hyder, A
    Dong, HH
    Kumar, M
    Ng, J
    Xu, E
    Lu, WY
    Wang, QH
    DIABETES, 2004, 53 : A357 - A357